Literature DB >> 15939308

Time reduction and process optimization of the baculovirus expression system for more efficient recombinant protein production in insect cells.

Björn Philipps1, Daniel Rotmann, Micha Wicki, Lorenz M Mayr, Michael Forstner.   

Abstract

Rapid expression of recombinant proteins for structure determination is one of the major challenges in pharmaceutical and academic research, since the number of potential drug targets has increased significantly in the last decade. Despite the fact that the baculovirus expression vector system is widely used for this purpose, the system is hampered by three very slow and tedious procedures, namely generation of high titer baculovirus stock, determination of the virus titer and discovery of the best conditions for protein expression. We herein describe the development of the ultraBac system to address and overcome these issues for protein expression in insect cells. We have established a new baculovirus expression technology for insect cells that is based on co-expression of GFP with target genes, a new regime for cell culturing and a highly efficient purification and enrichment procedure for recombinant baculovirus particles. Co-expression of GFP is used to monitor the infection of insect cells, to simplify titer determination and to optimize expression conditions. The new regime for cell culturing with increased viability of non-infected insect cells and its combination with the massive enrichment of virus particles via high-speed centrifugation enables the production of large amounts of recombinant virus in a very short period of time. By combining these techniques and by using the bicistronic vector pUltraBac-1, we have been able to cut the time-lines for protein expression in insect cells by half, approaching those for protein production in Escherichia coli. This new expression system is a significant step forward towards industrialized protein production in both, industry and academia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939308     DOI: 10.1016/j.pep.2005.03.020

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  10 in total

1.  Enhanced expression of recombinant proteins utilizing a modified baculovirus expression vector.

Authors:  Prabhakar Tiwari; Shalini Saini; Sanatan Upmanyu; Biju Benjamin; Ruchi Tandon; Kulvinder Singh Saini; Sudhir Sahdev
Journal:  Mol Biotechnol       Date:  2010-09       Impact factor: 2.695

2.  An Improved Model of Moderate Sleep Apnoea for Investigating Its Effect as a Comorbidity on Neurodegenerative Disease.

Authors:  Reno Roberts; Mark J Wall; Ingke Braren; Karendeep Dhillon; Amy Evans; Jack Dunne; Simbarashe Nyakupinda; Robert T R Huckstepp
Journal:  Front Aging Neurosci       Date:  2022-06-29       Impact factor: 5.702

3.  Insights into the Mechanism of Human Deiodinase 1.

Authors:  Alfonso Rodriguez-Ruiz; Doreen Braun; Simon Pflug; Alexander Brol; Marc Sylvester; Clemens Steegborn; Ulrich Schweizer
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

4.  Expression and purification of active receptor interacting protein 1 kinase using a baculovirus system.

Authors:  Jenny L Maki; J Tres Brazell; Xin Teng; Gregory D Cuny; Alexei Degterev
Journal:  Protein Expr Purif       Date:  2013-03-21       Impact factor: 1.650

5.  Expression of Functional Recombinant Human Tissue Transglutaminase (TG2) Using the Bac-to-Bac Baculovirus Expression System.

Authors:  Yaghoub Yazdani; Shahram Azari; Hamid Reza Kalhor
Journal:  Adv Pharm Bull       Date:  2016-03-17

6.  Manipulation of Subunit Stoichiometry in Heteromeric Membrane Proteins.

Authors:  Claudio L Morales-Perez; Colleen M Noviello; Ryan E Hibbs
Journal:  Structure       Date:  2016-03-31       Impact factor: 5.006

7.  Domain architecture of a calcium-permeable AMPA receptor in a ligand-free conformation.

Authors:  Charles R Midgett; Avinash Gill; Dean R Madden
Journal:  Front Mol Neurosci       Date:  2012-01-02       Impact factor: 5.639

Review 8.  Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential.

Authors:  Shimao Zhu; Caiping Guo
Journal:  Viruses       Date:  2016-10-28       Impact factor: 5.048

Review 9.  Vaccines for viral and parasitic diseases produced with baculovirus vectors.

Authors:  Monique M van Oers
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

10.  Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris.

Authors:  Chi-Pang Chuck; Chi-Hang Wong; Larry Ming-Cheung Chow; Kwok-Pui Fung; Mary Miu-Yee Waye; Stephen Kwok-Wing Tsui
Journal:  Virus Genes       Date:  2008-10-29       Impact factor: 2.332

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.